CONTRACT PHARMACAL FDA Approval ANDA 072299

ANDA 072299

CONTRACT PHARMACAL

FDA Drug Application

Application #072299

Application Sponsors

ANDA 072299CONTRACT PHARMACAL

Marketing Status

Over-the-counter001

Application Products

001TABLET;ORAL200MG0IBUPROFENIBUPROFEN

FDA Submissions

ORIG1AP1988-07-01
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1991-09-23
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1991-09-23
BIOEQUIV; BioequivalenceSUPPL4AP1989-12-12
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1993-08-24
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1994-06-28
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1996-07-24
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1996-07-23
LABELING; LabelingSUPPL10AP1999-12-01
LABELING; LabelingSUPPL12AP2004-09-29
LABELING; LabelingSUPPL14AP2006-03-31

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0

CDER Filings

CONTRACT PHARMACAL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 72299
            [companyName] => CONTRACT PHARMACAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"IBUPROFEN","activeIngredients":"IBUPROFEN","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"IBUPROFEN","submission":"IBUPROFEN","actionType":"200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.